Classification of Routes
| Category | Routes |
|---|
| Enteral | Oral, sublingual and buccal, rectal, and by nasogastric or gastrostomy tube |
| Parenteral — injection | Intravenous, intramuscular, subcutaneous, intradermal, intrathecal, intra-articular, intraperitoneal, intraosseous, intracardiac |
| Parenteral — other | Inhalational, transdermal, topical (skin, eye, ear, nose), vaginal, intranasal |
Enteral Routes Compared
| Route | Advantages | Disadvantages |
|---|
| Oral | Safest, most convenient, cheapest and most acceptable; self-administered; no sterility needed; a large overdose can sometimes be retrieved by lavage | Slow onset; unreliable absorption; destroyed by acid or enzymes (penicillin G, insulin); first-pass metabolism; useless in vomiting, coma, obstruction or an uncooperative patient; irritant drugs cause gastritis |
| Sublingual / buccal | Rapid absorption through a rich venous plexus draining into the superior vena cava, so it bypasses the portal circulation and avoids first-pass metabolism; the drug can be spat out if effects become excessive | Only for lipid-soluble, non-irritant, potent drugs in small volume — glyceryl trinitrate, nifedipine, buprenorphine, ondansetron |
| Rectal | Useful in vomiting, in the unconscious and in young children; partly avoids first-pass metabolism, since the lower and middle rectal veins drain systemically | Absorption is irregular; culturally unacceptable to many; local irritation. Used for diazepam in convulsions, paracetamol, and mesalazine |
CLINICAL PEARL
The sublingual route works because of where the blood goes, not because the mucosa is special. Venous drainage from beneath the tongue enters the superior vena cava directly, so the drug reaches the systemic circulation without passing through the liver. That is the whole reason sublingual glyceryl trinitrate acts within a minute while the swallowed tablet is useless — over 90% of it would be destroyed on first pass.
Parenteral Routes Compared
| Route | Onset and features | Cautions |
|---|
| Intravenous | Immediate and complete — bioavailability is 100% by definition. Allows titration to effect, large volumes, and irritant or hypertonic solutions. The route of choice in emergencies | Irreversible once given — the drug cannot be recalled; risk of sudden high concentration causing arrhythmia or collapse; thrombophlebitis, infection, air embolism, extravasation. Never for oily or insoluble preparations |
| Intramuscular | Onset in 10–30 minutes; absorption from the well-perfused muscle is fairly reliable; depot and oily preparations can be given | Painful; absorption is erratic in shock (muscle perfusion falls); contraindicated in bleeding disorders and on anticoagulants; nerve injury; raises creatine kinase, confusing cardiac enzyme interpretation |
| Subcutaneous | Slower and more sustained; self-administration is easy — insulin, heparin, adrenaline pens; implants and pellets give very prolonged release | Only small volumes of non-irritant drug; absorption unreliable in shock; lipodystrophy at repeated sites |
| Intrathecal | Places the drug directly in cerebrospinal fluid, bypassing the blood–brain barrier — spinal anaesthesia, methotrexate and cytarabine for CNS leukaemia, baclofen for spasticity | Requires absolute care — vincristine given intrathecally is invariably fatal, and this error has occurred repeatedly worldwide |
| Intraosseous | Rapid access when a vein cannot be found, especially in children and in cardiac arrest | Temporary; osteomyelitis |
| Intra-articular | High local concentration with minimal systemic effect — corticosteroid injection | Infection; repeated injection damages cartilage |
Other Routes
- Inhalational — the enormous alveolar surface gives rapid absorption for gases and volatile agents; for aerosols it delivers high airway concentrations with low systemic exposure, which is why inhaled corticosteroids can be given for years when oral ones cannot. Limited by technique and by particle size, and it can cause local irritation and bronchospasm
- Transdermal — patches give sustained, controlled release with no first-pass metabolism and good adherence (fentanyl, glyceryl trinitrate, nicotine, hyoscine, oestrogen). Only for potent, lipid-soluble drugs; heat increases absorption dangerously, and local reactions occur
- Topical — skin, eye, ear, nose, vagina; local effect with limited absorption, though systemic effects occur through inflamed or occluded skin, in infants, and from eye drops (timolol causing bronchospasm)
- Intranasal — rapid absorption avoiding first pass; desmopressin, sumatriptan, midazolam for seizures, and naloxone for community overdose reversal
Choosing a Route, and Newer Delivery Systems
- The choice depends on — the urgency; the physicochemical properties of the drug (acid stability, lipid solubility, first-pass extraction); the condition of the patient (vomiting, unconscious, shocked, uncooperative); whether a local or systemic effect is wanted; and cost and availability
- Prefer the oral route wherever it will work — injections in India are over-used and expected by patients, and carry real risks of abscess, nerve injury and transmission of hepatitis B, C and HIV through unsafe practice
- Sustained- and controlled-release preparations reduce dosing frequency and fluctuation, but must never be crushed, and overdose is prolonged and unpredictable
- Targeted delivery — liposomes (liposomal amphotericin B and doxorubicin, which reduce toxicity by altering distribution), nanoparticles, antibody-drug conjugates (trastuzumab-emtansine), and monoclonal antibody carriers
- Osmotic pumps, transdermal systems, ocular inserts and intrauterine systems deliver drug at a controlled rate over long periods, which transforms adherence
- Prodrugs — designed to improve absorption, palatability or targeting: enalapril, valaciclovir, levodopa, sulphasalazine
First-pass Metabolism and Bioavailability
A drug swallowed is absorbed from the gut into the portal vein → It passes through the liver before reaching the systemic circulation → Metabolism in the gut wall and liver removes part of the dose — first-pass (presystemic) metabolism → Only the surviving fraction reaches the site of action — the bioavailability → Routes that bypass the portal circulation avoid this entirely — sublingual, transdermal, inhalational, parenteral, and partly rectal
| Drug | Consequence of high first-pass extraction |
|---|
| Glyceryl trinitrate | Almost completely destroyed if swallowed — hence the sublingual, transdermal and intravenous routes |
| Lignocaine | Ineffective orally; given intravenously as an antiarrhythmic |
| Propranolol, morphine, verapamil | Oral doses must be much larger than parenteral ones; and bioavailability rises sharply in liver disease and portosystemic shunting, so the usual oral dose becomes an overdose |
| Levodopa | Over 95% decarboxylated peripherally — hence the addition of carbidopa |
| Insulin, penicillin G, heparin | Destroyed by gastric acid or enzymes rather than by the liver, but the result is the same — they cannot be given orally |
- Bioavailability is the fraction of an administered dose reaching the systemic circulation unchanged; it is 100% by definition for the intravenous route, against which all others are measured
- It is reduced by poor absorption, destruction in the gut, and first-pass metabolism; and altered by food, formulation, gastric emptying and interacting drugs
Applied Aspects
- Switch from intravenous to oral as soon as the patient can absorb; it reduces line infections, cost and length of stay, and is one of the easiest improvements available in any hospital
- Do not give intramuscular injections to a shocked patient — absorption is unreliable and the drug may be released unpredictably once perfusion is restored
- Adrenaline in anaphylaxis is intramuscular into the anterolateral thigh, not subcutaneous and not intravenous in the first instance; delay while seeking a vein has caused deaths
- Label and handle intrathecal drugs separately, never at the same time as intravenous cytotoxics; the vincristine error is the reason for this rule
- Unsafe injection practice remains a serious problem in India, and the cultural preference for injections should be actively addressed rather than accommodated
- Check that the patient can use the delivery device — an inhaler, a pen, a patch or a suppository is useless if it cannot be managed, and this is rarely asked about
- Reduce the oral dose of a high-extraction drug in liver disease; propranolol and morphine become far more available when the liver is bypassed or failing, and the standard dose then becomes toxic
- Sustained-release tablets must never be crushed for a patient with swallowing difficulty or a nasogastric tube — the entire dose is released at once, and deaths have followed
- Rotate injection sites for insulin and other repeated subcutaneous drugs; lipohypertrophy is painless, so patients prefer the damaged site, and absorption there is erratic
- Remember that eye drops are absorbed systemically through the nasal mucosa; punctal occlusion after instillation reduces this substantially and should be taught
- Depot preparations transform adherence in schizophrenia, contraception and rheumatic fever prophylaxis, and should be offered actively where regular tablet taking is the obstacle
- Rectal administration is under-used in children with convulsions or vomiting, and a family taught to give rectal or buccal midazolam prevents many emergency presentations
- Cost differs enormously between routes — an oral tablet may cost a fraction of the injectable equivalent, and in a system paid for out of pocket that difference decides whether treatment is completed
- Absorption from any injected site depends on blood flow, which is why exercise, heat and massage accelerate it and shock delays it — relevant to insulin, adrenaline and local anaesthetic alike